Clinical Trial: Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease

U.S., Feb. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07399600) titled 'Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease' on Nov. 17, 2025.

Brief Summary: The goal of this clinical trial is to learn if repetitive Transcranial Magnetic Stimulation (rTMS), a non-invasive brain stimulation technique, works to treat Metabolic dysfunction-associated and alcohol-associated liver disease (MetALD). The main questions it aims to answer are:

* Can rTMS effectively treat MetALD?

* Is an individualized, precision-targeted rTMS approach more effective than the standard rTMS method?

* What changes in brain activity are associated with the treatment? ...